| Campo DC | Valor | Idioma |
|---|
| dc.contributor.author | Stephen Doral Stefani | - |
| dc.contributor.author | Vanessa Teich | - |
| dc.contributor.author | André Poisl Fay | - |
| dc.contributor.author | Marcia Abadi | - |
| dc.contributor.author | Scott Flanders | - |
| dc.contributor.author | Cat Bui | - |
| dc.contributor.author | Andre Sasse | - |
| dc.date.accessioned | 2018-05-30T14:09:16Z | - |
| dc.date.available | 2018-05-30T14:09:16Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.issn | 2175-2095 | - |
| dc.identifier.uri | http://hdl.handle.net/10923/11627 | - |
| dc.language.iso | pt_BR | - |
| dc.relation.ispartof | Jornal Brasileiro de Economia da Saúde | - |
| dc.rights | openAccess | - |
| dc.title | Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspective | - |
| dc.type | Article | - |
| dc.date.updated | 2018-05-30T14:09:15Z | - |
| dc.jtitle | Jornal Brasileiro de Economia da Saúde | - |
| dc.volume | 7 | - |
| dc.issue | 3 | - |
| dc.spage | 127 | - |
| Aparece en las colecciones: | Artigo de Periódico
|
